Letter | Published:

KLF15 regulates endobiotic and xenobiotic metabolism

Abstract

Hepatic metabolism and elimination of endobiotics (for example, steroids, bile acids) and xenobiotics (for example, drugs, toxins) is essential for health. While the enzymatic (termed phase I–II) and transport machinery (termed phase III) controlling endobiotic and xenobiotic metabolism (EXM) is known, understanding of molecular nodal points that coordinate EXM function in physiology and disease remains incomplete. Here we show that the transcription factor Kruppel-like factor 15 (KLF15) regulates all three phases of the EXM system by direct and indirect pathways. Unbiased transcriptomic analyses coupled with validation studies in cells, human tissues, and animals, support direct transcriptional control of the EXM machinery by KLF15. Liver-specific deficiency of KLF15 (Li-KO) results in altered expression of numerous phase I–III targets, and renders animals resistant to the pathologic effects of bile acid and acetaminophen toxicity. Furthermore, Li-KO mice demonstrate enhanced degradation and elimination of endogenous steroid hormones, such as testosterone and glucocorticoid, resulting in reduced male fertility and blood glucose levels, respectively. Viral reconstitution of hepatic KLF15 expression in Li-KO mice reverses these phenotypes. Our observations identify a previously unappreciated transcriptional pathway regulating metabolism and elimination of endobiotics and xenobiotics.

Access optionsAccess options

Rent or Buy article

Get time limited or full article access on ReadCube.

from$8.99

All prices are NET prices.

Data availability

RNA-seq data have been deposited in Gene Expression Omnibus (GEO) under accession code GSE126762.

Ethics declarations

Competing interests

The authors declare no competing interests. A patent based on this manuscript has been submitted. The patent applicant is Case Western Reserve University. The inventors are Shuxin Han and Mukesh K. Jain. The application number is US Provisional Patent Application No. 62/810,080. The status of the application is pending. The specific aspect of the manuscript covered in the patent application is ‘Transient Inhibition of KLF15 Resists Liver Injury’.

Additional information

Publisher’s note: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

References

  1. 1.

    Kuntz, E., Gundermann, K. J. & Schneider, E. “Essential” phospholipids in hepatology (experimental and clinical tests) (in Russian). Ter. Arkh 66, 66–72 (1994).

  2. 2.

    Urquhart, B. L., Tirona, R. G. & Kim, R. B. Nuclear receptors and the regulation of drug-metabolizing enzymes and drug transporters: implications for interindividual variability in response to drugs. J. Clin. Pharmacol. 47, 566–578 (2007).

  3. 3.

    Chai, X., Zeng, S. & Xie, W. Nuclear receptors PXR and CAR: implications for drug metabolism regulation, pharmacogenomics and beyond. Expert Opin. Drug Metab. Toxicol. 9, 253–266 (2013).

  4. 4.

    Copple, I. M., Goldring, C. E., Kitteringham, N. R. & Park, B. K. The Nrf2-Keap1 defence pathway: role in protection against drug-induced toxicity. Toxicology 246, 24–33 (2008).

  5. 5.

    Baird, L. & Dinkova-Kostova, A. T. The cytoprotective role of the Keap1-Nrf2 pathway. Arch. Toxicol. 85, 241–272 (2011).

  6. 6.

    McConnell, B. B. & Yang, V. W. Mammalian Kruppel-like factors in health and diseases. Physiol. Rev. 90, 1337–1381 (2010).

  7. 7.

    Haldar, S. M., Ibrahim, O. A. & Jain, M. K. Kruppel-like factors (KLFs) in muscle biology. J. Mol. Cell Cardiol. 43, 1–10 (2007).

  8. 8.

    Gray, S. et al. Regulation of gluconeogenesis by Kruppel-like factor 15. Cell Metab. 5, 305–312 (2007).

  9. 9.

    Jeyaraj, D. et al. Klf15 orchestrates circadian nitrogen homeostasis. Cell Metab. 15, 311–323 (2012).

  10. 10.

    Haldar, S. M. et al. Kruppel-like factor 15 regulates skeletal muscle lipid flux and exercise adaptation. Proc. Natl Acad. Sci. USA 109, 6739–6744 (2012).

  11. 11.

    Takeuchi, Y. et al. KLF15 enables rapid switching between lipogenesis and gluconeogenesis during fasting. Cell Rep. 16, 2373–2386 (2016).

  12. 12.

    Han, S. et al. Circadian control of bile acid synthesis by a KLF15-Fgf15 axis. Nat. Commun. 6, 7231 (2015).

  13. 13.

    Jung, D. Y. et al. KLF15 is a molecular link between endoplasmic reticulum stress and insulin resistance. PLoS ONE 8, e77851 (2013).

  14. 14.

    Prakash, C. et al. Nuclear receptors in drug metabolism, drug response and drug interactions. Nucl. Receptor Res. 2, 101178 (2015).

  15. 15.

    Shen, G. & Kong, A. N. Nrf2 plays an important role in coordinated regulation of Phase II drug metabolism enzymes and Phase III drug transporters. Biopharm. Drug Dispos. 30, 345–355 (2009).

  16. 16.

    Zhang, J., Huang, W., Chua, S. S., Wei, P. & Moore, D. D. Modulation of acetaminophen-induced hepatotoxicity by the xenobiotic receptor CAR. Science 298, 422–424 (2002).

  17. 17.

    Coles, B. et al. The spontaneous and enzymatic reaction of N-acetyl-p-benzoquinonimine with glutathione: a stopped-flow kinetic study. Arch. Biochem. Biophys. 264, 253–260 (1988).

  18. 18.

    Cooke, G. M. & Gower, D. B. Attempted solubilization of boar testis microsomal ‘androsta-5,16-dien-3 beta-ol synthetase’. Biochem. Soc. Trans. 7, 920–922 (1979).

  19. 19.

    Kumar, R. et al. Compensatory changes in CYP expression in three different toxicology mouse models: CAR-null, Cyp3a-null, and Cyp2b9/10/13-null mice. PLoS ONE 12, e0174355 (2017).

  20. 20.

    Zimniak, P., Awasthi, S. & Awasthi, Y. C. Phase III detoxification system. Trends Biochem. Sci. 18, 164–166 (1993).

  21. 21.

    Rebbeck, T. R. et al. Effect of hormone metabolism genotypes on steroid hormone levels and menopausal symptoms in a prospective population-based cohort of women experiencing the menopausal transition. Menopause 17, 1026–1034 (2010).

  22. 22.

    Sten, T., Finel, M., Ask, B., Rane, A. & Ekstrom, L. Non-steroidal anti-inflammatory drugs interact with testosterone glucuronidation. Steroids 74, 971–977 (2009).

  23. 23.

    Zhang, B. et al. Pregnane X receptor as a therapeutic target to inhibit androgen activity. Endocrinology 151, 5721–5729 (2010).

  24. 24.

    Park, B. C., Lee, Y. C. & Strott, C. A. Testosterone sulfotransferase: evidence in the guinea pig that this reaction is carried out by 3 alpha-hydroxysteroid sulfotransferase. Steroids 64, 510–517 (1999).

  25. 25.

    Ambadapadi, S., Wang, P. L., Palii, S. P. & James, M. O. Celecoxib influences steroid sulfonation catalyzed by human recombinant sulfotransferase 2A1. J. Steroid Biochem. Mol. Biol. 152, 101–113 (2015).

  26. 26.

    Mason, B. L., Pariante, C. M. & Thomas, S. A. A revised role for P-glycoprotein in the brain distribution of dexamethasone, cortisol, and corticosterone in wild-type and ABCB1A/B-deficient mice. Endocrinology 149, 5244–5253 (2008).

  27. 27.

    Yates, C. R. et al. Structural determinants of P-glycoprotein-mediated transport of glucocorticoids. Pharm. Res. 20, 1794–1803 (2003).

  28. 28.

    Qadri, I. et al. Interaction of hepatocyte nuclear factors in transcriptional regulation of tissue specific hormonal expression of human multidrug resistance-associated protein 2. Toxicol. Appl. Pharmacol. 234, 281–292 (2009).

  29. 29.

    Tien, E. S. & Negishi, M. Nuclear receptors CAR and PXR in the regulation of hepatic metabolism. Xenobiotica 36, 1152–1163 (2006).

  30. 30.

    Teshigawara, K. et al. Role of Kruppel-like factor 15 in PEPCK gene expression in the liver. Biochem. Biophys. Res. Commun. 327, 920–926 (2005).

  31. 31.

    Trapnell, C. et al. Differential analysis of gene regulation at transcript resolution with RNA-seq. Nat. Biotechnol. 31, 46–53 (2013).

  32. 32.

    Cheng, Y. et al. Abnormal sperm in mice lacking the Taf7l gene. Mol. Cell Biol. 27, 2582–2589 (2007).

  33. 33.

    Liston, C. & Gan, W. B. Glucocorticoids are critical regulators of dendritic spine development and plasticity in vivo. Proc. Natl Acad. Sci. USA 108, 16074–16079 (2011).

  34. 34.

    Ishida, Y. et al. Opposite roles of neutrophils and macrophages in the pathogenesis of acetaminophen-induced acute liver injury. Eur. J. Immunol. 36, 1028–1038 (2006).

  35. 35.

    Sasse, S. K. et al. The glucocorticoid receptor and KLF15 regulate gene expression dynamics and integrate signals through feed-forward circuitry. Mol. Cell Biol. 33, 2104–2115 (2013).

  36. 36.

    Cui, J. Y., Gunewardena, S. S., Rockwell, C. E. & Klaassen, C. D. ChIPing the cistrome of PXR in mouse liver. Nucleic Acids Res. 38, 7943–7963 (2010).

  37. 37.

    Ikeda, H. et al. Activation of mouse Pi-class glutathione S-transferase gene by Nrf2(NF-E2-related factor 2) and androgen. Biochem. J. 364, 563–570 (2002).

Download references

Acknowledgements

We thank the Liver Tissue Cell Distribution System at University of Minnesota for providing liver tissues. We acknowledge the University Hospitals Laboratory Core for the mouse blood tests. We wish to thank J. Chiang (Northeast Ohio Medical University) for his critical advice. We also thank H.-Y. Kao for human NRF2 plasmid. This research is supported by grants 1R35HL135789, 1R01DK111468-01, and AHA EIA14370009 (to M.K.J.) and T32GM007250 and F30HL139014 (to D.R.S.). We thank S. Haldar for sharing unpublished ChIP-seq data.

Author information

S.H. and M.K.J. conceived the project. S.H. and J.W.R. performed most experiments. S.H. and M.K.J. designed the research. S.H., J.W.R., N.J., and M.K.J. co-wrote the manuscript. P.P. performed EMSA. R.Z. contributed to bile duct ligation and tail-vein injection studies. D.R.S. co-wrote the manuscript, and contributed to RNA isolation for the RNA-seq experiment and Fig. 4o. H.G. and D.I.S. contributed to Fig. 4l,m. W.X. contributed to several in vitro experiments. E.H.K. performed transfection and luciferase reporter assays. E.R.C. analysed the RNA-seq data and contributed to Fig. 1a and Supplementary Fig. 1b.

Correspondence to Shuxin Han or Mukesh K. Jain.

Supplementary information

Supplementary Information

Supplementary Figures 1–16 and Supplementary Tables 1–4

Reporting Summary

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark
Fig. 1: Bile acids and acetaminophen inhibit hepatic KLF15 through PXR activation.
Fig. 2: Hepatic KLF15 deficiency resists BDL-induced BA toxicity.
Fig. 3: Depletion of hepatic KLF15 robustly resists acetaminophen overdose-induced toxicity and acute liver failure.
Fig. 4: Hepatic KLF15 deficiency enhances EXM biotransformation and elimination of testosterone and corticosterone leading to reduced reproduction and blood glucose.